Enjoy complimentary customisation on priority with our Enterprise License!
Vaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, and adolescent, ranging from birth to 21 years of age. However, the EMA classifies pediatrics as ranging from birth to 18 years of age. According to the preventable vaccines industry analysis, this market is expected to grow at a CAGR of 10.16 percent over the period 2014-2019.
This report covers the present scenario and the growth prospects of the global preventable vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of preventable vaccines. The report examines the market for vaccines used in humans. It covers only commercialized vaccines for diseases that are vaccine preventable.
The report does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Ebola infection, Epstein-Ban virus infection, Alzheimer's disease, diabetes, Helicobacter pylori infection, multiple sclerosis, Parkinson's disease, or West Nile virus infections.
The report has broadly categorized preventable vaccines into two major segments:
• Adult Preventable Vaccines
• Pediatric Preventable Vaccines
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Vaccine Approval Process
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019
07.4 Five Forces Analysis
08. Market Segmentation by Type of Vaccine
08.1 Live Attenuated Vaccine
08.2 Killed Vaccine
08.3 Toxoid Vaccine
08.4 Genetically Modified/Engineered Vaccine
09. Market Segmentation by Product Type
09.1 Polysaccharide Vaccines
09.2 Conjugate Vaccines
10. Geographical Segmentation
11. Global Preventable Vaccines Market by Key Geographies
11.1 Market Size and Forecast for the US
11.2 Market Size and Forecast for the EU
11.3 Market Size and Forecast for Japan
11.4 Market Size and Forecast for India
11.5 Market Size and Forecast for China
12. Global Pediatric Preventable Vaccines Market
12.1 Global Pediatric Preventable Vaccine Market
12.1.1 Market Size and Forecast
12.2 Market Segmentation of the Global Pediatric Preventable Vaccine Market
12.3 Global Pediatric Hepatitis Vaccines Market
12.3.1 Market Size and Forecast
12.4 Global Pediatric Haemophilus Influenzae Type B (Hib) Vaccines Market
12.4.1 Market Size and Forecast
12.5 Global Pediatric MMR Vaccines Market
Market Size and Forecast
12.6 Global Pediatric Combination Vaccines Market
12.6.1 Market Size and Forecast
12.7 Global Pediatric Pneumococcal Vaccines Market
12.7.1 Market Size and Forecast
12.8 Global Polio Vaccines Market
12.8.1 Market Size and Forecast
12.9 Global Pediatric Varicella Vaccines Market
12.9.1 Market Size and Forecast
12.10 Global Other Pediatric Vaccines Market
12.10.1 Market Size and Forecast
12.11 Global Pediatric Preventable Vaccines Market 2014 and 2019 (by percentage)
13. Global Adult Preventable Vaccines Market
13.1 Market Size and Forecast
13.2 Market Segmentation of the Global Adult Preventable Vaccines Market
13.3 Global Adult Cervical Vaccines Market
13.3.1 Market Size and Forecast
13.4 Global Adult Hepatitis Vaccines Market
13.4.1 Market Size and Forecast
13.5 Global Adult Influenza Vaccines Market
13.5.1 Market Size and Forecast
13.6 Global Adult Pneumococcal Vaccines Market
13.6.1 Market Size and Forecast
13.7 Global Adult Travel, Diphtheria-Tetanus, and Miscellaneous Vaccines Market
13.7.1 Market Size and Forecast
14. Key Leading Countries
14.1 US
14.2 China
14.3 Japan
14.4 India
15. Buying Criteria
16. Market Growth Drivers
17. Drivers and their Impact
18. Market Challenges
19. Impact of Drivers and Challenges
20. Market Trends
21. Trends and their Impact
22. Vendor Landscape
22.1 Competitive Scenario
22.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2014
22.2.1 GlaxoSmithKline
22.2.2 Merck
22.2.3 Novartis
22.2.4 Pfizer
22.2.5 Sanofi
22.3 Other Prominent Vendors
23. Key Vendor Analysis
23.1 GlaxoSmithKline
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Business Segmentation
23.1.4 Business Segmentation by Revenue 2012 and 2013
23.1.5 Sales by Geography
23.1.6 Pipeline Products
23.1.7 Business Strategy
23.1.8 Key Information
23.1.9 SWOT Analysis
23.2 Merck
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business Segmentation by Revenue 2013
23.2.4 Business Segmentation by Revenue 2012 and 2013
23.2.5 Sales by Geography
23.2.6 Business Strategy
23.2.7 Key Developments
23.2.8 SWOT Analysis
23.3 Novartis
23.3.1 Key Facts
23.3.2 Business Description
23.3.3 Business Segmentation
23.3.4 Revenue by Business Segmentation
23.3.5 Revenue Comparison 2012 and 2013
23.3.6 Sales by Geography
23.3.7 Business Strategy
23.3.8 Key Developments
23.3.9 SWOT Analysis
23.4 Pfizer
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2012 and 2013
23.4.5 Geographical Segmentation by Revenue
23.4.6 Business Strategy
23.4.7 Key Developments
23.4.8 SWOT Analysis
23.5 Sanofi
23.5.1 Key Facts
23.5.2 Business Description
23.5.3 Business Segmentation
23.5.4 Revenue by Business Segmentation
23.5.5 Revenue Comparison 2012 and 2013
23.5.6 Sales by Geography
23.5.7 Business Strategy
23.5.8 Key Developments
23.5.9 SWOT Analysis
24. Other Reports in this Series
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.